Form 4: Danaher Corp Director Feroz Dewan Reports Acquisition of Phantom Shares

Sentiment:

SEC Form 4 Filing


Director Feroz Dewan reports acquiring phantom shares of Danaher Corp through a deferred compensation plan.

Summary

  • On April 26, 2024, Feroz Dewan, a director of Danaher Corp, acquired 126.681 phantom shares through the company's Non-Employee Directors Deferred Compensation Plan.
  • These phantom shares are based on deferred cash director fees and dividend accruals, converted into notional shares of Danaher common stock.
  • The conversion price was $246.58 per share, reflecting the closing price of Danaher's common stock on the transaction date.
  • Following the transaction, Dewan beneficially owns 991.986 phantom shares.
  • The phantom shares convert into actual shares of Danaher common stock on a one-for-one basis upon distribution, and Dewan is fully vested in all deferred amounts.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating a neutral to slightly positive sentiment as it demonstrates continued alignment of director interests with the company's performance.

Positives

  • The acquisition of phantom shares reflects Dewan's continued investment in Danaher Corp.
  • The deferred compensation plan aligns director interests with the long-term performance of the company.

Future Outlook

The document does not contain specific forward-looking statements beyond the mechanics of the deferred compensation plan.

Industry Context

Directors often receive compensation in the form of equity or equity-linked instruments to align their interests with those of shareholders. Deferred compensation plans are a common way to provide this alignment while also offering tax benefits to the director.

Comparison to Industry Standards

  • Deferred compensation plans for directors are a common practice among publicly traded companies, including those in the industrial and healthcare sectors, where Danaher operates.
  • Companies like Siemens, Roche, and Abbott also utilize similar compensation structures to incentivize their board members.
  • The specific terms of these plans, such as vesting schedules and conversion ratios, can vary based on company policy and market conditions.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders.
  • It reinforces the alignment of director interests with shareholder value through equity-based compensation.

Key Dates

DateDescription
04/26/2024Date of transaction: Acquisition of phantom shares.
04/29/2024Date of report signature.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.